These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1323168)

  • 1. [Human mammary carcinoma. A model for the relationship between tumor proliferation, tumor-associate macrophages, and prognostic factors].
    Müller H
    Veroff Pathol; 1992; 138():1-235. PubMed ID: 1323168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.
    Laoui D; Movahedi K; Van Overmeire E; Van den Bossche J; Schouppe E; Mommer C; Nikolaou A; Morias Y; De Baetselier P; Van Ginderachter JA
    Int J Dev Biol; 2011; 55(7-9):861-7. PubMed ID: 22161841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies.
    Schorlemmer HU; Bosslet K; Kern HF; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):240-64. PubMed ID: 3408453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
    Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
    No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages.
    Munn DH; McBride M; Cheung NK
    Cancer Res; 1991 Feb; 51(4):1117-23. PubMed ID: 1825476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.
    Anderson DC; Miller LJ; Schmalstieg FC; Rothlein R; Springer TA
    J Immunol; 1986 Jul; 137(1):15-27. PubMed ID: 3519773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1.
    Beck T; Weller EE; Weikel W; Brumm C; Wilkens C; Knapstein PG
    Gynecol Oncol; 1995 Apr; 57(1):96-104. PubMed ID: 7705708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
    Ueno T; Toi M; Saji H; Muta M; Bando H; Kuroi K; Koike M; Inadera H; Matsushima K
    Clin Cancer Res; 2000 Aug; 6(8):3282-9. PubMed ID: 10955814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
    Hand PH; Nuti M; Colcher D; Schlom J
    Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.